OCTOPLUS SCIENCES BV has a total of 30 patent applications. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Brazil. Its main competitors in its focus markets pharmaceuticals, chemical engineering and macromolecular chemistry and polymers are NEKTAR THERAPEUTICS UK LTD, UNIV MINAS GERAIS and NANNING MAPLE LEAF PHARMACEUTI.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 13 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Brazil | 2 | |
#4 | Canada | 2 | |
#5 | United States | 2 | |
#6 | Australia | 1 | |
#7 | China | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | New Zealand | 1 | |
#11 | Russian Federation | 1 |
# | Name | Total Patents |
---|---|---|
#1 | Verrijk Rudolf | 10 |
#2 | Bezemer Jeroen Mattijs | 7 |
#3 | Bechet Anne Chantal | 6 |
#4 | Hiemstra Pieter Sicco | 6 |
#5 | Nell Maartje Johanna | 6 |
#6 | Stigter Martin | 6 |
#7 | Grote Johannes Jakobus | 6 |
#8 | Vonk Marcel Jan | 6 |
#9 | Bloemberg Guido Vincent | 5 |
#10 | Drijfhout Jan Wouter | 5 |
Publication | Filing date | Title |
---|---|---|
WO2008100142A2 | Vaccine formulation | |
EP2054039A2 | Viscoelastic aqueous gels comprising microspheres | |
EP2090592A1 | Biodegradable hydrogels based on click chemistry | |
EP2025334A1 | Sustained release drug delivery system for repeated administration | |
EP1985284A1 | Vaccine formulation | |
BRPI0513856A | use of a peptide compound | |
EP1679065A1 | Controlled release compositions for interferon based on PEGT/PBT block copolymers | |
US7468151B2 | Method for the preparation of purified microparticles | |
EP1393718A1 | Colloidal drug carrier system | |
EP1384489A1 | Biocompatible scaffold as a dermal or cartilage substitute |